Cyclo Therapeutics
Why Robinhood?
You can watch CYTH and buy or sell other stocks, ETFs, and their options commission-free!About CYTH
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease.
CYTH Key Statistics
Stock Snapshot
The current Cyclo Therapeutics(CYTH) stock price is $0.72, with a market capitalization of 20.62M. The stock trades at a price-to-earnings (P/E) ratio of -0.81.
During the trading day, Cyclo Therapeutics(CYTH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Cyclo Therapeutics(CYTH) stock has reached 0, versus its average volume of 22.85K.
Over the past 52 weeks, Cyclo Therapeutics(CYTH) stock has traded between a high of $1.62 and a low of $0.55.
Over the past 52 weeks, Cyclo Therapeutics(CYTH) stock has traded between a high of $1.62 and a low of $0.55.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.